06/07/2024 1:03 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 1:23 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 6:48 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 3:14 PM | Eli Lilly and Company (Issuer) Rau Diogo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 5:29 PM | Eli Lilly and Company (Subject) Zakrowski Donald A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 5:30 PM | Eli Lilly and Company (Subject) Norton Johna (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 3:14 PM | Eli Lilly and Company (Issuer) Norton Johna (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/31/2024 1:32 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 2:13 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024 3:18 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:19 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 2:20 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024 11:04 AM | Eli Lilly and Company (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024 6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:11 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:12 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:13 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 3:14 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 11:59 AM | AS YOU SOW (Filed by) Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024 12:10 PM | Chevedden John (Filed by) Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024 11:20 AM | Eli Lilly and Company (Subject) Trinity Health Corp (Filed by)
| Form PX14A6G | |
03/11/2024 3:24 PM | Eli Lilly and Company (Subject) Zakrowski Donald A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 3:26 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:16 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 3:18 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 10:44 AM | Eli Lilly and Company (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 2:05 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 3:43 PM | Dozier Eric (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:44 PM | Eli Lilly and Company (Issuer) White Anne E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:34 PM | Eli Lilly and Company (Issuer) Hakim Anat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:36 PM | Eli Lilly and Company (Issuer) Skovronsky Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:23 PM | Eli Lilly and Company (Issuer) Rau Diogo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:25 PM | Eli Lilly and Company (Issuer) Jonsson Patrik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 10:56 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 8:26 AM | Eli Lilly and Company (Subject) PNC FINANCIAL SERVICES GROUP, INC. (Filed by)
| Form SC 13G/A | |
02/08/2024 2:34 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024 4:08 PM | Eli Lilly and Company (Subject)
| Form FWP | |
02/07/2024 7:12 AM | Eli Lilly and Company (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
02/06/2024 6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 3:32 PM | Eli Lilly and Company (Issuer) Hakim Anat (Reporting) Hakim Anat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 3:20 PM | Eli Lilly and Company (Issuer) White Anne E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Shocking $16T Elon Musk Crypto Leak (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
01/29/2024 2:26 PM | BlackRock Inc. (Filed by) Eli Lilly and Company (Subject)
| Form SC 13G/A | |
01/17/2024 3:15 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:17 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2024 3:19 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 2:22 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 3:05 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 1:15 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 2:11 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 5:40 PM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/18/2023 5:59 AM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/04/2023 3:17 PM | Eli Lilly and Company (Issuer) Zakrowski Donald A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 6:04 AM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/21/2023 3:27 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:29 PM | Eli Lilly and Company (Issuer) Runge Marschall S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:15 PM | Baicker Katherine (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:18 PM | Eli Lilly and Company (Issuer) Fyrwald J Erik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:20 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:22 PM | Eli Lilly and Company (Issuer) JACKSON JAMERE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 3:24 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/17/2023 5:53 AM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/15/2023 5:51 AM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/08/2023 4:06 PM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/06/2023 5:09 PM | Eli Lilly and Company (Subject) Zakrowski Donald A (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023 3:25 PM | Eli Lilly and Company (Issuer) Zakrowski Donald A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 10:21 AM | Eli Lilly and Company (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 6:02 AM | Eli Lilly and Company (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/27/2023 3:15 PM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
10/17/2023 3:19 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:21 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:22 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:24 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:15 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:18 PM | Eli Lilly and Company (Issuer) Fyrwald J Erik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2023 5:52 AM | Eli Lilly and Company (Filed by) POINT Biopharma Global Inc. (Subject)
| Form SC TO-T | |
10/12/2023 3:00 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 1:06 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 3:25 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:27 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:28 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:29 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:22 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2023 3:24 PM | Eli Lilly and Company (Issuer) Fyrwald J Erik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 3:14 PM | Eli Lilly and Company (Issuer) Weems Alonzo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 3:26 PM | Eli Lilly and Company (Subject) Weems Alonzo (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023 1:37 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2023 12:44 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2023 3:33 PM | Eli Lilly and Company (Issuer) Sulzberger Gabrielle (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2023 3:34 PM | Eli Lilly and Company (Issuer) Zakrowski Donald A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2023 3:24 PM | Alvarez Ralph (Reporting) Eli Lilly and Company (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2023 3:26 PM | Eli Lilly and Company (Issuer) Fyrwald J Erik (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Shocking $16T Elon Musk Crypto Leak (Ad) Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market.
Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account."
Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. |
08/22/2023 3:28 PM | Eli Lilly and Company (Issuer) Hedley Mary Lynne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2023 3:29 PM | Eli Lilly and Company (Issuer) JOHNSON KIMBERLY H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2023 3:31 PM | Eli Lilly and Company (Issuer) LUCIANO JUAN R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2023 3:00 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2023 12:31 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023 2:50 PM | Eli Lilly and Company (Issuer) LILLY ENDOWMENT INC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 7:34 AM | Eli Lilly and Company (Filed by) Sigilon Therapeutics, Inc. (Subject)
| Form SC TO-T/A | |
08/09/2023 1:32 PM | Eli Lilly and Company (Subject) LILLY ENDOWMENT INC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023 8:14 AM | DICE Therapeutics, Inc. (Subject) Eli Lilly and Company (Filed by)
| Form SC TO-T/A | |